I was referring to the slowing sales growth in the last quarter. Did you read the announcement?
Growth fell off a cliff for AVH.
It used covid as an excuse except that excuse is weak given PNV grew sales by 33% for the quarter.
- Forums
- ASX - By Stock
- AVH
- AVH on NASDAQ
AVH on NASDAQ, page-514
-
- There are more pages in this discussion • 430 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.86 |
Change
0.100(3.62%) |
Mkt cap ! $195.4M |
Open | High | Low | Value | Volume |
$2.84 | $2.92 | $2.84 | $427.4K | 149.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1700 | $2.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.87 | 4036 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3746 | 2.860 |
5 | 11197 | 2.850 |
4 | 14252 | 2.840 |
1 | 167 | 2.820 |
1 | 5000 | 2.810 |
Price($) | Vol. | No. |
---|---|---|
2.880 | 22551 | 4 |
2.890 | 4575 | 2 |
2.900 | 26673 | 8 |
2.910 | 4586 | 3 |
2.920 | 9500 | 3 |
Last trade - 11.47am 16/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online